ClinConnect ClinConnect Logo
Search / Trial NCT06700694

Technology-Assisted Early Mobilization Program Among Patients in the Intensive Care Units

Launched by HSIAO-YEAN CHIU · Nov 19, 2024

Trial Information

Current as of June 26, 2025

Not yet recruiting

Keywords

ClinConnect Summary

This clinical trial is studying how different methods of early movement can help patients who are critically ill and may develop weakness from being in the intensive care unit (ICU). Researchers want to see if using technology to assist in movement, along with family support, is more effective than standard movement practices or just regular care. They will be enrolling 138 patients who are 18 years or older, have been on a ventilator for at least 24 hours, and are expected to stay in the ICU for more than four days. Participants will be divided into three groups: one will receive technology-assisted movement, another will get systematic movement without technology, and the last group will receive routine care.

Participants in the trial can expect to take part in activities aimed at improving their muscle strength, sleep, and overall well-being while in the ICU and after they leave. The study will track their progress at various points, including during their ICU stay and six months after they leave the hospital. It’s important to know that some people, such as those with certain medical conditions or severe muscle weakness, may not be eligible to join the trial.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Aged ≥ 18 years
  • Being mechanically ventilated ≥ 24 hours
  • Richmond Agitation-Sedation Scale (RASS): 0 to -1
  • No vision, hearing, or body movements restriction
  • With clear consciousness and ability to communicate in Chinese
  • Expected to stay in the ICU \> 96 hours.
  • Exclusion Criteria:
  • Being pregnant, menopausal, or having a night shift within one month before admission to the ICU
  • Have developed delirium before enrollment (ICDSC \> 4)
  • With acute physiology and chronic health evaluation (APACHE II) score \> 25 after ICU admission within 24 hours
  • With muscle weakness caused by severe acute brain injury (e.g., traumatic brain injury or stroke), spinal coral injury, other neuromuscular conduction diseases, or long-term bedridden or hemiplegia.

About Hsiao Yean Chiu

Hsiao-Yean Chiu is a dedicated clinical trial sponsor focused on advancing medical research and improving patient outcomes through innovative therapeutic interventions. With a strong commitment to scientific rigor and ethical standards, the organization collaborates with leading research institutions and healthcare professionals to design, implement, and oversee clinical trials across various therapeutic areas. By leveraging cutting-edge methodologies and fostering a culture of transparency and collaboration, Hsiao-Yean Chiu aims to contribute significantly to the development of safe and effective treatments, ultimately enhancing the quality of care for patients worldwide.

Locations

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported